Edition:
United Kingdom

Kaken Pharmaceutical Co Ltd (4521.T)

4521.T on Tokyo Stock Exchange

5,810JPY
17 Nov 2017
Change (% chg)

¥80 (+1.40%)
Prev Close
¥5,730
Open
¥5,720
Day's High
¥5,830
Day's Low
¥5,700
Volume
215,400
Avg. Vol
148,973
52-wk High
¥6,970
52-wk Low
¥5,410

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep 24,893.00 133.751
Jun 24,967.00 133.795
FY 2017 Mar '17 22,514.00 98.698
Dec 26,786.00 159.946
Sep 25,951.00 137.956
Jun 26,228.00 140.030
FY 2016 Mar '16 24,299.00 24.370
Dec 30,458.00 184.771
Sep 27,340.00 149.294
Jun 27,633.00 152.082
FY 2015 Mar '15 22,734.00 60.744
Dec 26,923.00 95.714
Sep 22,768.00 72.253
Jun 21,464.00 62.360
 
*Note: Units in Millions ofYen
**Note: Units in Yen

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Mar-17 2 102,850.00 102,900.00 102,800.00 --
Year Ending Mar-18 2 100,450.00 100,700.00 100,200.00 108,500.00
Year Ending Mar-19 2 97,000.00 97,200.00 96,800.00 106,850.00
Earnings (per share)
Year Ending Mar-17 2 516.11 520.83 511.40 --
Year Ending Mar-18 2 481.95 490.20 473.70 574.08
Year Ending Mar-19 2 443.96 458.82 429.10 541.23
Sales and Profit Figures in Japanese Yen (JPY);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 10.75 31.15 32.96
P/E High - Last 5 Yrs. 23.93 40.78 45.57
P/E Low - Last 5 Yrs. 11.72 23.79 24.35
Beta 0.05 0.90 0.89
Price to Sales (TTM) 2.76 3.94 5.25
Price to Book (MRQ) 2.22 4.83 5.40
Price to Tangible Book (MRQ) 2.66 5.47 6.73
Price to Cash Flow (TTM) 11.65 23.18 23.58
% Owned Institutions -- 0.77 1.29

Dividends

  Company industry sector
Dividend Yield 2.63 1.54 1.48
Dividend Yield - 5 Year Avg 2.20 1.54 1.49
Dividend 5 Year Growth Rate 13.40 4.38 5.23
Payout Ratio(TTM) 28.27 45.05 43.12

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -4.81 3.32 8.84
Sales (TTM) vs TTM 1 Yr. Ago -7.48 4.75 5.41
Sales - 5 Yr. Growth Rate 2.89 10.23 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago -4.45 16.20 19.37
EPS (TTM) vs TTM 1 Yr. Ago 6.41 -- --
EPS - 5 Yr. Growth Rate 23.75 10.04 10.96
Capital Spending - 5 Yr. Growth Rate -1.42 15.37 15.32

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.90 2.12 2.20
Current Ratio (MRQ) 3.51 2.91 3.00
LT Debt to Equity (MRQ) 0.00 8.63 10.82
Total Debt to Equity (MRQ) 3.72 12.47 14.95
Interest Coverage (TTM) -- 37.12 33.97

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 56.23 54.92 54.68
Gross Margin - 5 Yr. Avg. 52.81 52.01 52.15
EBITD Margin (TTM) 32.20 -- --
EBITD - 5 Yr. Avg 26.75 18.41 15.51
Operating Margin (TTM) 30.05 14.62 9.27
Operating Margin - 5 Yr. Avg. 24.12 14.52 11.18
Pre-Tax Margin (TTM) 30.62 15.10 10.08
Pre-Tax Margin - 5 Yr. Avg. 23.83 14.85 11.61
Net Profit Margin (TTM) 21.64 11.35 6.37
Net Profit Margin - 5 Yr. Avg. 15.38 11.16 7.88
Effective Tax Rate (TTM) 29.34 23.30 23.20
Effective Tax Rate - 5 Yr. Avg. 35.46 23.46 24.03

Efficiency

  Company industry sector
Revenue/Employee (TTM) 71,329,536 967,481,775 876,721,579
Net Income/Employee (TTM) 15,432,740 113,847,942 103,151,091
Receivable Turnover (TTM) 3.24 5.62 5.78
Inventory Turnover (TTM) 2.86 2.58 3.35
Asset Turnover (TTM) 0.75 0.96 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 16.16 11.53 11.10
Return on Assets - 5 Yr. Avg. 12.68 13.15 12.57
Return on Investment (TTM) 20.51 14.99 14.58
Return on Investment - 5 Yr. Avg. 17.38 17.20 16.46
Return on Equity (TTM) 22.34 16.33 16.09
Return on Equity - 5 Yr. Avg. 19.27 18.16 17.62
  1 Year 3 Year 5 Year
Sales % -7.52 4.49 2.89
EPS (TTM) % 5.13 32.97 23.75
Dividend % 10.29 16.04 13.40
Note: Units in Millions of US Dollars

Performance for Kaken Pharmaceutical Co Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.71 -4.88 47 25
13 Week -2.90 -7.51 48 36
26 Week -12.04 -22.33 37 30
52 Week -10.94 -28.53 39 12
YTD -8.06 -17.25 34 23
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 29.73%
# of Holders: 123
Total Shares Held: 14,402,370
3 Mo. Net Change: -390,060
# New Positions: 8
# Closed Positions: 2
# Increased Positions: 26
# Reduced Positions: 19
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.